Middle East and Africa Point of Care Diagnostics Market Growth and Analysis by 2028

The MEA point of care diagnostics market is expected to grow from US$ 2,484.03 million in 2021 to US$ 5,433.77 million by 2028; it is estimated to grow at a CAGR of 11.8% from 2021 to 2028.

The UAE, South Africa, and Saudi Arabia are major economies in MEA region. Growth in the use of home-based poc devices is expected to escalate the market growth. The increasing awareness about point of care testing is bringing the test conveniently and quickly to the patient at home. Most clinicians recognize POC testing as a requirement for early detection of life-threatening situations because laboratory results can be made available in real-time. POC diagnostic and monitoring devices are anticipated to become universal in-home setups as well as at doctor’s offices or hospitals, in low- and middle-income countries. Consumers are frequently using smartphones as platform devices. The health and monitoring applications of smartphones commonly include imaging, sensing, and diagnostics. Although glucose meters are widely used in home settings by diabetic patients, they can also be repurposed to perform common clinical assays such as immunoassays, molecular diagnostics, and enzymatic assays. The rise in geriatric population has resulted in increased expenditure on healthcare for health checkups, disease diagnoses, and treatments. The most constant health problems affecting this population include digestive disorders, cardiovascular diseases, bone and joint diseases, diabetes, and different types of cancer. The people of this age group claim diagnostic testing on a regular basis, owing to their low immunity and metabolism. Therefore, these factors have increased the demand of POCs for diagnostic purposes across MEA region.

In case of COVID-19, MEA is highly affected specially Turkey. Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in deep economic recession due to the US sanctions. Also, the major source of economic stabilization in Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East region. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage, are major impacts observed in the region. The Saudi government policies are favored of domestic pharmaceutical manufacturers including not any import duties on raw materials & intermediate products and interest-free funding support the growth of the pharmaceutical market in this region. Similarly, increasing incidence of COVID-19 create huge demand for kits and reagent used in detection of covid-19 virus. In April 2020, BGI Group, a Chinese genomics company, and Group-42, a UAE technology company, unveiled a new massive-throughput laboratory in the UAE to help with testing and diagnosis of the novel coronavirus. According to BGI, the lab will use RT-PCR diagnostic kits that have been approved by medical regulatory authorities in China, Europe, the United States, and Japan. As point of care diagnostics kits are majorly used in detection of novel coronavirus, so there was high impact of covid-19 on the point of care diagnostics market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA point of care diagnostics market. The MEA point of care diagnostics market is expected to grow at a good CAGR during the forecast period. 

MEA Point of Care Diagnostics Market Segmentation      

MEA Point of Care Diagnostics Market – By Product

• Glucose Monitoring Products
• Infectious Disease Testing Products
  • HIV Testing
  • Influenza Testing
  • Sexually Transmitted Disease (STD) Testing
  • Hepatitis C Testing
  • Healthcare-Associated Infection (HAI) Testing
  • Tropical Disease Testing
  • Respiratory Infection Testing
  • Other Infectious Disease Testing
• Cardiometabolic Testing Products
• Pregnancy and Fertility Testing Products
• Coagulation Testing Products
• Tumor/Cancer Marker Testing Products
• Cholesterol Testing Products
• Urinalysis Testing Products
• Hematology Testing Products
• Other POC Products

MEA Point of Care Diagnostics Market – By Prescription Mode

• Prescription-Based Testing
• OTC Testing

MEA Point of Care Diagnostics Market – By End User

• Professional Diagnostic Centers
  • Hospitals
  • Clinical Laboratories
  • Outpatient Healthcare
  • Ambulatory Care Settings
• Home Care
• Research Laboratories
• Others

MEA Point of Care Diagnostics Market, by Country

• UAE     
• Saudi Arabia 
• South Africa
• Rest of MEA

MEA Point of Care Diagnostics Market -Companies Mentioned

• Abbott
• BD    
• bioMerieux SA 
• BIO-RAD LABORATORIES INC.
• Danaher
• F. HOFFMANN-LA ROCHE LTD.
• Johnson and Johnson Services, Inc.    
• Nova Biomedical
• Polymer Technology Systems, Inc. (PTS)    
• Siemens AG

Middle East and Africa Point of Care Diagnostics Report Scope